Search Results



Your search for Jo Cavallo matches 31 pages

Showing 1 - 31


gynecologic cancers
survivorship

Survivors of Uterine Cancer Have Increased Risk of Heart Disease Years After Treatment Has Ended

A large population-based study by Soisson et al examining the long-term cardiovascular outcomes among survivors of endometrial cancer has found that women were at higher risk for a number of cardiovascular risks, including hypertension; diseases of the arteries, arterioles, and capillaries;...

breast cancer
gynecologic cancers
cost of care

Population-Based Screening for Breast and Ovarian Cancer Genetic Mutations Appears Cost-Effective

The cost-effectiveness of population-based panel testing for the known high- and moderate-penetrance ovarian and breast cancer mutations, including BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, and PALB2, was not known. Now, a study evaluating the cost-effectiveness of screening the general population for...

gynecologic cancers

Study Finds HPV Screening May Be More Sensitive Than Pap Test for Detecting Cervical Cancer

The main goal of cervical screening programs is to detect and treat precancer before the cancer develops. Human papillomavirus (HPV) testing is more sensitive than cytology for detecting precancer. However, reports of rare HPV-negative, cytology-positive cancers are motivating the continued use of...

gynecologic cancers

Current Performance Measures for Cervical Cancer Screening

Health-care systems use performance measures for cervical cancer screening based on guidelines from such organizations as the American College of Obstetricians and Gynecologists to monitor the appropriateness of cervical cancer screening. According to the performance measure in the Healthcare...

gynecologic cancers

Preclinical Study of PI3K/mTOR Inhibitors in Uterine Leiomyosarcomas

According to the National Cancer Institute, uterine sarcomas are rare gynecologic malignancies comprising between 2% and 5% of all uterine malignancies. Leiomyosarcomas, which arise from myometrial muscle, account for 30% of all uterine sarcomas. These aggressive, rare cancers are characterized by...

gynecologic cancers

Intentional Weight Loss in Postmenopausal Women May Be Linked to Reduced Endometrial Cancer Risk

Although many studies have linked obesity with an increased risk for endometrial cancer, information about the influence of weight loss on the cancer in postmenopausal women has been limited. Now, a study by Luo et al evaluating the association of weight change and endometrial cancer risk among...

gynecologic cancers

Women With High-Grade Cervical Intraepithelial Neoplasia Have Long-Term Increased Risk for HPV-Related Anal, Vulvar, and Vaginal Cancers

Although high-risk human papillomavirus (HPV) is essential for developing high-grade cervical intraepithelial neoplasia (CIN2 and CIN3) and has also been associated with noncervical anogenital cancers, little is known about the long-term risk for anal, vulvar, and vaginal cancer following a...

gynecologic cancers

Neoadjuvant Chemotherapy May Render Advanced Ovarian Cancers Responsive to Immunotherapy

Although most patients with advanced ovarian cancer initially respond to platinum-based chemotherapy, they usually relapse. According to a study by Böhm et al published in Clinical Cancer Research, neoadjuvant chemotherapy seemed to alter the immune cells in the tumors of patients with...

gynecologic cancers

Moore Scoring System Helps Identify Women With Advanced Cervical Cancer Who May Not Benefit From Bevacizumab

Previously published reports from the randomized phase III Gynecologic Oncology Group (GOG) protocol 240 clinical trial showed that adding bevacizumab (Avastin) to a chemotherapy regimen of paclitaxel plus cisplatin or topotecan significantly increased overall survival and progression-free survival ...

gynecologic cancers
issues in oncology

How Physicians Communicate With Parents May Discourage HPV Vaccination of Adolescents

A nationwide online survey of 776 pediatricians and family physicians assessing the quality of their human papillomavirus (HPV) vaccine recommendations to parents has found that a sizable minority of physicians—27%—said they do not strongly endorse HPV vaccination, and 26% and 39%...

gynecologic cancers
gynecologic cancers
issues in oncology

Study Finds Improving Cervical Cancer Screening Practice May Generate Health Gains With Nominal Increases in Cost

Cytology-based screening has led to substantial declines in cervical cancer incidence and mortality since it was introduced in the 1940s. A population-based, cost-effective analysis investigating the benefits, costs, and cost-effectiveness of current cervical cancer screening practice, however, has ...

gynecologic cancers

Intraperitoneal Plus Intravenous Chemotherapy—an Underused Strategy—May Improve Survival in Advanced Ovarian Cancer

An observational study investigating the use and effectiveness of a combination regimen of intraperitoneal and intravenous chemotherapy in the treatment of advanced-stage ovarian cancer has found that although the dual approach substantially improved survival—81% of those treated with the...

gynecologic cancers
issues in oncology

Investigators Identify Gene That Prevents Immune Response in Ovarian Cancer

Researchers have identified a gene in dendritic cells that disables an effective immune response against ovarian cancer tumors. In preclinical studies, the researchers found that silencing this gene, XBP1, in dendritic cells restores their function and enhances T-cell antitumor immunity. XBP1 is...

breast cancer
gynecologic cancers
colorectal cancer
gynecologic cancers
prostate cancer
issues in oncology

American College of Physicians Offers Advice on High-Value Screening in Five Cancers

To provide guidance on high-value cancer care screening strategies, the American College of Physicians (ACP) recently reviewed clinical guidelines issued by various medical organizations for screening strategies in five common cancers for asymptomatic, average-risk adults. The five cancers focused...

gynecologic cancers
sarcoma

American College of Physicians Releases Best Practice Advice for Cervical Cancer Screening in Average-Risk Women

The American College of Physicians (ACP) released its clinical advice for cervical cancer screening in asymptomatic, average-risk women 21 years or older. Women at average risk are defined as those with no history of a precancerous lesion (cervical intraepithelial neoplasia grade 2 or a more severe ...

gynecologic cancers

Age-Stratified Predictive Model May Provide Surgical Guidelines for Uterine Leiomyomas

A study by Brohl et al investigating the case incidence of unexpected uterine sarcoma following surgery for presumed benign leiomyoma (fibroids or myomas) has found that the risk of unexpected uterine sarcoma varies significantly across age groups, with a more than fivefold difference between the...

gynecologic cancers

Early Study Suggests Olaparib May Be Effective in Ovarian Cancers Expressing High Levels of POLQ

Last December, the U.S. Food and Drug Administration (FDA) approved olaparib (Lynparza) in the treatment of advanced ovarian cancer in women with BRCA1 or BRCA2 gene mutations. Now, a laboratory study by Ceccaldi et al has found that the drug may also be effective in breast and ovarian tumors that...

gynecologic cancers

Metabolic Syndrome Linked With Higher Risk of Endometrial Cancer Regardless of Being Overweight or Obese

A large population-based analysis of women 65 and older in the United States diagnosed with endometrial cancer has found that women with metabolic syndrome—characterized by low HDL cholesterol, hypertension, high triglycerides, and elevated waist circumference—have an increased risk of...

gynecologic cancers

Next-Generation HPV Vaccine May Prevent 90% of Cervical Cancer Cases Worldwide

A study of a nine-valent human papillomavirus (HPV) vaccine that provides protection against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58, has found it to be highly safe and efficacious. If vaccination programs with this new-generation vaccine are effectively implemented, approximately 90% of...

gynecologic cancers

Olaparib Tablet Found Safe and Effective in Heavily Pretreated Patients With Ovarian Cancer

A phase Ib clinical trial of the tablet form of olaparib, a PARP inhibitor, in combination with paclitaxel and carboplatin chemotherapy in heavily pretreated patients with advanced-stage ovarian cancer finds the drug to be safe and effective, especially in those women with BRCA gene mutations. The...

gynecologic cancers
issues in oncology

American College of Physicians Issues Guideline Recommending Against Routine Pelvic Exams for Asymptomatic Women

A new evidence-based clinical practice guideline from the American College of Physicians (ACP) is recommending that physicians should not offer routine pelvic examinations to asymptomatic, average-risk, nonpregnant women. The recommendation stems from a review of 52 published articles from 1946...

gynecologic cancers
issues in oncology

Study Identifies Two Proteins as Markers of Response to Neoadjuvant Chemotherapy for Ovarian Cancer

A study by researchers from Danbury Hospital Biomedical Research Institute in Connecticut has found that patients with ovarian cancer who relapse shortly after neoadjuvant chemotherapy to shrink their tumor prior to surgery have high levels of expression of HGF and c-Met proteins. The...

gynecologic cancers

Researchers Identify Enzymes Associated With Chemoresistance in Ovarian Cancer

Inhibiting enzymes that cause changes in gene expression could decrease chemotherapy resistance in patients with ovarian cancer, according to research by Cacan et al. The study investigated the silencing of RGS10 expression in ovarian cells by epigenetics and identified two epigenetic regulators,...

gynecologic cancers

Human Papillomavirus Vaccine Proves Effective in Women With HIV

Women infected with HIV are disproportionally affected by human papillomavirus (HPV)-related anogenital disease, particularly with increased immunosuppression. In a clinical study of 319 HIV-infected women in the United States, Brazil, and South Africa, researchers assessed the immunogenicity and...

gynecologic cancers
issues in oncology

Study Shows 20% of Women With Ovarian Cancer Have Inherited Genetic Mutations That Increase Risk of Disease

A large-scale genetic analysis of women with ovarian cancer with no known family histories of breast or ovarian cancer has found that one-fifth of them had inherited alterations in genes known to be associated with these cancers. The findings could lead to the development of better screening...

gynecologic cancers
issues in oncology

One Dose of HPV 16/18 Vaccine Produces Durable Response Against New Infections

Results from the Costa Rica HPV16/18 Vaccine Trial (CVT) has found that 4-year efficacy against 12-month HPV16/18 persistent infection was similarly high among women who received one, two, or the recommended three doses of the bivalent HPV16/18 L1 virus-like particle vaccine (Cervarix). The...

gynecologic cancers
issues in oncology

African American Women Are Less Likely to Benefit From HPV Vaccines for Cervical Cancer Prevention

Vaccines currently available to prevent the two most common strains of human papillomavirus (HPV), HPV 16 and 18, responsible for about 70% of cervical cancers, may not be protective in African American women, according to a study by Cathrine Hoyo, PhD, MPH, Associate Professor in the Obstetrics...

gynecologic cancers

Genomic Differences Found in Two Types of Cervical Cancer

A study by Alexi Wright, MD, MPH, and colleagues at Dana-Farber Cancer Institute and Brigham and Women’s Hospital in Boston has found that two common subtypes of cervical cancer, adenocarcinoma and squamous cell carcinoma, have distinct molecular profiles. The results suggest that clinical...

gynecologic cancers

New Study Supports Role of Epithelial-to-Mesenchymal Transition in Patients With Ovarian Cancer

In a study of ovarian cancer cells taken from patients, scientists from Georgia Institute of Technology have confirmed that metastasizing cancer cells have a different molecular structure from primary tumor cells and display genetic signatures consistent with epithelial-to-mesenchymal transition....

gynecologic cancers
head and neck cancer
issues in oncology

CDC Report Shows Stagnated HPV Vaccination Rate for Girls

For the first time since the human papillomavirus (HPV) vaccine became available for adolescent girls in 2006, the vaccination rate for the teenagers has stalled, according to data published in the Centers for Disease Control and Prevention’s (CDC’s) Morbidity and Mortality Weekly...

gynecologic cancers
gynecologic cancers
issues in oncology

Study Shows HPV Vaccine Reduced Rate of Infection in Teenage Girls by 56%

A new government study investigating the prevalence of human papillomavirus (HPV) infections in females aged 14 to 59 before and after the introduction in 2006 of the HPV vaccine found that the rate of the HPV infection dropped by 56%, decreasing from 11.5% in 2006 to 5.1% in 2010 among female...

Advertisement

Advertisement



;
Advertisement

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.